LifeMD Correlations
LFMD Stock | USD 6.47 0.67 11.55% |
The current 90-days correlation between LifeMD Inc and HealthStream is 0.41 (i.e., Very weak diversification). The correlation of LifeMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
LifeMD Correlation With Market
Very weak diversification
The correlation between LifeMD Inc and DJI is 0.46 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LifeMD Inc and DJI in the same portfolio, assuming nothing else is changed.
LifeMD |
Moving together with LifeMD Stock
0.73 | ENOV | Enovis Corp | PairCorr |
0.74 | FOXO | FOXO Technologies | PairCorr |
0.61 | ITGR | Integer Holdings Corp | PairCorr |
0.62 | MMSI | Merit Medical Systems | PairCorr |
0.74 | CRVL | CorVel Corp | PairCorr |
Moving against LifeMD Stock
0.63 | FIGS | Figs Inc | PairCorr |
0.4 | EVH | Evolent Health | PairCorr |
0.39 | PHG | Koninklijke Philips | PairCorr |
0.38 | AMN | AMN Healthcare Services | PairCorr |
0.35 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.34 | SSY | SunLink Health Systems | PairCorr |
0.49 | EQ | Equillium | PairCorr |
0.31 | DOMH | Dominari Holdings | PairCorr |
0.71 | EXAS | EXACT Sciences | PairCorr |
0.46 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.45 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.31 | LLY | Eli Lilly | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between LifeMD Stock performing well and LifeMD Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LifeMD's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
STRM | 7.24 | (0.99) | 0.00 | (1.05) | 0.00 | 19.40 | 55.52 | |||
HSTM | 1.22 | 0.08 | 0.06 | 0.21 | 1.32 | 2.33 | 10.49 | |||
NRC | 2.00 | (0.31) | 0.00 | (0.05) | 0.00 | 4.51 | 13.17 | |||
CPSI | 1.50 | (0.12) | 0.00 | 0.43 | 0.00 | 2.85 | 14.25 | |||
NXGN | 1.10 | (0.08) | 0.00 | 0.54 | 0.00 | 2.81 | 7.28 | |||
PRVA | 2.00 | (0.09) | 0.01 | 0.07 | 2.14 | 4.30 | 15.04 | |||
EVH | 3.11 | (1.44) | 0.00 | (1.22) | 0.00 | 4.48 | 51.11 | |||
CCLDO | 2.45 | 0.67 | 0.19 | (0.95) | 1.98 | 6.15 | 35.94 | |||
CCLDP | 2.38 | 0.97 | 0.46 | (2.05) | 1.04 | 6.44 | 34.13 |
LifeMD Corporate Management
Alexander Mironov | President | Profile | |
Dennis Wijnker | Chief Officer | Profile | |
Tameca Brown | VP HR | Profile | |
Marc Benathen | Chief Officer | Profile | |
Varun Pathak | Chief Simpli | Profile | |
Shane Biffar | Chief Counsel | Profile | |
Jessica Friedeman | Chief Officer | Profile |